华东医药（西安）博华制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
59
NMPA:59
Drug Approvals
Vonoprazan Fumarate Tablets
- Product Name
- 富马酸伏诺拉生片
- Approval Number
- 国药准字H20254478
- Approval Date
- Jun 10, 2025
NMPA
Lornoxicam for Injection
- Product Name
- 注射用氯诺昔康
- Approval Number
- 国药准字H20249127
- Approval Date
- Oct 22, 2024
NMPA
Cefetame Pivoxil Hydrochloride Tablets
- Product Name
- 盐酸头孢他美酯片
- Approval Number
- 国药准字H20090119
- Approval Date
- Jan 11, 2024
NMPA
Pregabalin Oral Solution
- Product Name
- 普瑞巴林口服溶液
- Approval Number
- 国药准字H20234408
- Approval Date
- Oct 27, 2023
NMPA
Acetohydroxamic Acid Capsules
- Product Name
- 醋羟胺酸胶囊
- Approval Number
- 国药准字H61022134
- Approval Date
- Nov 12, 2020
NMPA
Compound Bismuth Subnitrate Tablets
- Product Name
- 复方石菖蒲碱式硝酸铋片
- Approval Number
- 国药准字H61023502
- Approval Date
- Nov 12, 2020
NMPA
Compound Paracetamol Tablets
- Product Name
- 复方对乙酰氨基酚片
- Approval Number
- 国药准字H61022243
- Approval Date
- Nov 12, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found